Get the Stockscreener App
2.06
9.25%
-0.21
After Hours:
2.13
0.07
+3.40%
60 Degrees Pharmaceuticals Inc stock is traded at $2.06, with a volume of 74,155.
It is down -9.25% in the last 24 hours and down -46.49% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$2.27
Open:
$2.28
24h Volume:
74,155
Relative Volume:
0.02
Market Cap:
$2.65M
Revenue:
$1.35M
Net Income/Loss:
$-7.97M
P/E Ratio:
-0.0837
EPS:
-24.6063
Net Cash Flow:
$-6.88M
1W Performance:
-30.41%
1M Performance:
-46.49%
6M Performance:
-63.48%
1Y Performance:
-68.21%
1-Day Range:
$2.04
$2.31
1-Week Range:
$2.04
$3.25
52-Week Range:
$1.36
$17.68
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
2.06 | 2.92M | 1.35M | -7.97M | -6.88M | -24.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
Short Squeeze: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising rates2025 Geopolitical Influence & AI Forecasted Stock Moves - baoquankhu1.vn
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Ames Tribune
SXTP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
[424B5] 60 DEGREES PHARMACEUTICALS, INC. Prospectus Supplement (Debt Securities) - Stock Titan
Movement Recap: Should I trade or invest in 60 Degrees Pharmaceuticals Inc Equity Warrant2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Palm Beach Daily News
SXTP PE Ratio & Valuation, Is SXTP Overvalued - Intellectia AI
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Derrick
Aug Summary: How is 60 Degrees Pharmaceuticals Inc managing supply chain issuesMarket Growth Report & Consistent Growth Stock Picks - baoquankhu1.vn
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA - Finviz
Forecast Cut: Is 60 Degrees Pharmaceuticals Inc stock technically oversold - baoquankhu1.vn
10 Best Up and Coming Penny Stocks to Buy - Insider Monkey
SXTP60 degrees pharmaceuticals, Inc. Latest Stock News & Market Updates - Stock Titan
Aug Movers: Is 60 Degrees Pharmaceuticals Inc Equity Warrant part of any major indexTrade Ideas & Verified Swing Trading Watchlist - baoquankhu1.vn
What’s the outlook for 60 Degrees Pharmaceuticals Inc. Equity Warrant’s sectorWeekly Profit Analysis & Reliable Breakout Forecasts - mfd.ru
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - The Asheville Citizen Times
Can 60 Degrees Pharmaceuticals Inc. stock double in next 5 yearsMarket Risk Analysis & High Accuracy Trade Alerts - mfd.ru
Analyzing Rafael (NYSE:RFL) & 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
Pullback Watch: Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a top pick in the sector2025 Buyback Activity & Daily Entry Point Trade Alerts - mfd.ru
Will 60 Degrees Pharmaceuticals Inc. benefit from sector rotationMarket Sentiment Report & Technical Confirmation Trade Alerts - mfd.ru
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from geopolitical trendsMarket Performance Recap & Free Low Drawdown Momentum Trade Ideas - mfd.ru
Trade Recap: How sensitive is 60 Degrees Pharmaceuticals Inc to inflation2025 Analyst Calls & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Dip Buying: Can 60 Degrees Pharmaceuticals Inc Equity Warrant maintain sales growthDay Trade & Real-Time Volume Triggers - baoquankhu1.vn
Will 60 Degrees Pharmaceuticals Inc. outperform its industry peersTake Profit & Short-Term Swing Trade Alerts - mfd.ru
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant grow without external funding2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - mfd.ru
Why 60 Degrees Pharmaceuticals Inc. stock could outperform in 2025July 2025 EndofMonth & Weekly Return Optimization Plans - mfd.ru
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock is a must watch in 2025Market Activity Report & Verified Trade Idea Suggestions - mfd.ru
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant maintain sales growthEarnings Recap Report & Risk Managed Investment Strategies - mfd.ru
SXTP Technical Analysis & Stock Price Forecast - Intellectia AI
Can 60 Degrees Pharmaceuticals Inc. stock sustain revenue growthJuly 2025 Setups & Safe Entry Momentum Tips - mfd.ru
60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status - The Globe and Mail
60 Degrees Pharmaceuticals company regained compliance with Nasdaq minimum bid price - marketscreener.com
60 Degrees Pharmaceuticals Regains Nasdaq Compliance - TradingView
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant face regulatory challengesJuly 2025 Selloffs & Real-Time Stock Price Movement Reports - mfd.ru
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from government policyWeekly Volume Report & Weekly Momentum Stock Picks - mfd.ru
What’s the fair value of 60 Degrees Pharmaceuticals Inc. stockWeekly Trade Analysis & Technical Confirmation Trade Alerts - mfd.ru
Can 60 Degrees Pharmaceuticals Inc. continue delivering strong returnsPortfolio Update Report & Weekly Breakout Watchlists - mfd.ru
Published on: 2026-02-09 21:05:09 - mfd.ru
Returns Recap: Is Hut 8 Corp stock suitable for long term investingTrade Exit Summary & AI Optimized Trading Strategy Guides - baoquankhu1.vn
60 Degrees Pharmaceuticals (SXTP) Price Target Increased by 300.00% to 17.95 - Nasdaq
RSI Check: Can 60 Degrees Pharmaceuticals Inc. be recession proofJuly 2025 Fed Impact & Short-Term Trading Alerts - baoquankhu1.vn
Quarterly Trades: Can 60 Degrees Pharmaceuticals Inc. Equity Warrant maintain sales growth2025 Key Highlights & Verified Short-Term Trading Plans - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. (SXTP) Stock: Pulls Back as GoodRx Partnership Fails to Lift Sentiment - parameter.io
60 Degrees Pharmaceuticals Partners with GoodRx to List FDA-Approved Antimalarial Drug ARAKODA for Price Comparisons - geneonline.com
60 Degrees Pharmaceuticals stock falls after GoodRx partnership announcement By Investing.com - Investing.com India
60 Degrees Pharmaceuticals stock falls after GoodRx partnership announcement - Investing.com
Malaria prevention pill ARAKODA gets GoodRx discounts at 70,000 pharmacies - Stock Titan
Rate Cut: How does 60 Degrees Pharmaceuticals Inc score in quality rankings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Patterns Watch: Can 60 Degrees Pharmaceuticals Inc Equity Warrant continue delivering strong returns - baoquankhu1.vn
HC Wainwright Has Bearish Estimate for SXTP FY2025 Earnings - Defense World
60 Degrees Pharmaceuticals shares slide after Nasdaq flags delisting risk - MSN
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
| XU CHERYL | Director |
Jun 03 '25 |
Buy |
2.88 |
5,000 |
14,410 |
15,816 |
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):